BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17652236)

  • 1. Tobacco industry lawyers as "disease vectors".
    Guardino SD; Daynard RA
    Tob Control; 2007 Aug; 16(4):224-8. PubMed ID: 17652236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lawyer control of internal scientific research to protect against products liability lawsuits. The Brown and Williamson documents.
    Hanauer P; Slade J; Barnes DE; Bero L; Glantz SA
    JAMA; 1995 Jul; 274(3):234-40. PubMed ID: 7609232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.
    Tan CE; Kyriss T; Glantz SA
    PLoS Med; 2013; 10(5):e1001450. PubMed ID: 23723740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.
    Douglas CE; Davis RM; Beasley JK
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv9-16. PubMed ID: 17130629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Playing hide-and-seek with the tobacco industry.
    LeGresley EM; Muggli ME; Hurt RD
    Nicotine Tob Res; 2005 Feb; 7(1):27-40. PubMed ID: 15804675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Product liability.
    Daynard RA; Legresley E
    Tob Control; 2012 Mar; 21(2):227-8. PubMed ID: 22345254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tobacco Deposition and Trial Testimony Archive (DATTA) project: origins, aims, and methods.
    Davis RM; Douglas CE; Beasley JK
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv4-8. PubMed ID: 17130623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest.
    Bitton A; Neuman MD; Barnoya J; Glantz SA
    Lancet; 2005 Feb 5-11; 365(9458):531-40. PubMed ID: 15705463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Litigation in Argentina: challenging the tobacco industry.
    Flores ML; Barnoya J; Mejia R; Alderete E; PĂ©rez-Stable EJ
    Tob Control; 2006 Apr; 15(2):90-6. PubMed ID: 16565455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking through a keyhole at the tobacco industry. The Brown and Williamson documents.
    Glantz SA; Barnes DE; Bero L; Hanauer P; Slade J
    JAMA; 1995 Jul; 274(3):219-24. PubMed ID: 7609230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Big tobacco is watching: British American Tobacco's surveillance and information concealment at the Guildford depository.
    Muggli ME; LeGresley EM; Hurt RD
    Lancet; 2004 May; 363(9423):1812-9. PubMed ID: 15172782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of British American Tobacco's questionable use of privilege and protected document claims at the Guildford Depository.
    LeGresley E; Lee K
    Tob Control; 2017 May; 26(3):316-322. PubMed ID: 27354678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destroyed documents: uncovering the science that Imperial Tobacco Canada sought to conceal.
    Hammond D; Chaiton M; Lee A; Collishaw N
    CMAJ; 2009 Nov; 181(10):691-8. PubMed ID: 19828670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking.
    Cummings KM; Morley CP; Hyland A
    Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I110-7. PubMed ID: 11893821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco control implications of the first European product liability suit.
    Hiilamo HT
    Tob Control; 2005 Feb; 14(1):22-30. PubMed ID: 15735296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lawyer control of the tobacco industry's external research program. The Brown and Williamson documents.
    Bero L; Barnes DE; Hanauer P; Slade J; Glantz SA
    JAMA; 1995 Jul; 274(3):241-7. PubMed ID: 7609233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette company trade secrets are not secret: an analysis of reverse engineering reports in internal tobacco industry documents released as a result of litigation.
    Velicer C; Lempert LK; Glantz S
    Tob Control; 2015 Sep; 24(5):469-80. PubMed ID: 24920577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Tobacco Industry's Abuse of Scientific Evidence and Activities to Recruit Scientists During Tobacco Litigation.
    Lee S
    J Prev Med Public Health; 2016 Jan; 49(1):23-34. PubMed ID: 26841882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco industry influence on the definition of tobacco related disorders by the American Psychiatric Association.
    Neuman MD; Bitton A; Glantz SA
    Tob Control; 2005 Oct; 14(5):328-37. PubMed ID: 16183984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.